| Dr Heidi Lynn Sensenig, OD | |
|
50 Berkshire Ct, Wyomissing, PA 19610-1219 | |
| (610) 374-3134 | |
| (610) 374-0484 |
| Full Name | Dr Heidi Lynn Sensenig |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 50 Berkshire Ct, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285886358 | NPI | - | NPPES |
| 1285886358 | Other | PA | VISION SERVICE PLAN |
| 50082253 | Other | PA | CAPITAL BLUE CROSS |
| 5586009 | Other | PA | AETNA |
| 6732446 | Other | PA | AETNA HMO |
| OEG002147 | Other | PA | HUMANA |
| SE2071705 | Other | PA | HIGHMARK BLUE SHIELD |
| 1285886358 | Other | PA | AMERIHEALTH/HMO |
| 1285886358 | Other | PA | CIGNA HEALTH |
| 1285886358 | Other | PA | HEALTH ASSURANCE |
| 3547521000 | Other | PA | KEYSTONE EAST |
| 50082253 | Other | PA | CBC/POS |
| OEG002147 | Other | PA | CORESOURCE |
| 1285886358 | Other | PA | AMERIHEALTH/TPA |
| 1285886358 | Other | PA | CIGNA VISION |
| 50082253 | Other | PA | CBC/TRADITIONAL |
| PA04743 | Other | PA | VISION BENEFITS OF AMERICA |
| 29435 | Other | PA | SPECTERA/WOC |
| OEG002147 | Other | PA | BERKSHIRE HEALTH PARTNERS |
| OEG002147 | Other | PA | LOOMIS |
| 29436 | Other | PA | SPECTERA/DOU |
| 3547521000 | Other | PA | INDEPENDENCE |
| 50082253 | Other | PA | CBC/SENIOR BLUE/PPO |
| 54284003 | Other | PA | DAVIS AFFINITY |
| OEG002147 | Other | PA | DEVON |
| SE2071705 | Other | PA | HIGHMARK/CLASSIC BLUE |
| SE2071705 | Other | PA | HIGHMARK/FREEDOM BLUE |
| 122423 | Other | PA | GEISINGER HEALTH PLAN |
| 1285886358 | Other | PA | HEALTH AMERICA/COVENTRY |
| 3547521000 | Other | PA | INDEPENDENCE PERSONAL CHOICE |
| 50082253 | Other | PA | CBC/KEYSTONE HEALTH CENTRAL |
| 5586009 | Other | PA | AETNA/PPO |
| 5586009 | Other | PA | AETNA/MEDICARE |
| SE2071705 | Other | PA | HIGHMARK/PPO BLUE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG002147 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Angiotensin, Angiotensin-Converting Enzyme 2, Cell, Coronavirus, Enzyme, Glycoprotein, Neck, Protein, Receptor, Respiratory, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus, SARS-CoV-2, Coronavirus Disease COVID-19,
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
Integrated Modular Systems, Inc. (IMSI) has announced OneList™, a unified worklist at RSNA 2010. IMSI will be in Booth 4606 at RSNA 2010 (the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America) November 27, 2010-December 3, 2010 at McCormick Place in Chicago, IL.
Many cancers could be successfully treated if the patient consulted the doctor sufficiently early. But how can a developing cancer be detected if it doesn't give rise to any symptoms? In the near future, suitably early diagnosis could be provided by simple and cheap chemical sensors - thanks to special recognizing polymer films developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.
Men's hidden fears about body fat are fuelling gym attendance motivated by feelings of guilt and shame rather than a desire to build muscle, new research has shown.
› Verified 6 days ago
| Provider Name | Wyomissing Optometric Center, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366404345 PECOS PAC ID: 3274427208 Enrollment ID: O20040211000407 |
News Archive
Angiotensin, Angiotensin-Converting Enzyme 2, Cell, Coronavirus, Enzyme, Glycoprotein, Neck, Protein, Receptor, Respiratory, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus, SARS-CoV-2, Coronavirus Disease COVID-19,
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
Integrated Modular Systems, Inc. (IMSI) has announced OneList™, a unified worklist at RSNA 2010. IMSI will be in Booth 4606 at RSNA 2010 (the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America) November 27, 2010-December 3, 2010 at McCormick Place in Chicago, IL.
Many cancers could be successfully treated if the patient consulted the doctor sufficiently early. But how can a developing cancer be detected if it doesn't give rise to any symptoms? In the near future, suitably early diagnosis could be provided by simple and cheap chemical sensors - thanks to special recognizing polymer films developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.
Men's hidden fears about body fat are fuelling gym attendance motivated by feelings of guilt and shame rather than a desire to build muscle, new research has shown.
› Verified 6 days ago
| Provider Name | Lehigh Valley Physician Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Angiotensin, Angiotensin-Converting Enzyme 2, Cell, Coronavirus, Enzyme, Glycoprotein, Neck, Protein, Receptor, Respiratory, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus, SARS-CoV-2, Coronavirus Disease COVID-19,
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
Integrated Modular Systems, Inc. (IMSI) has announced OneList™, a unified worklist at RSNA 2010. IMSI will be in Booth 4606 at RSNA 2010 (the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America) November 27, 2010-December 3, 2010 at McCormick Place in Chicago, IL.
Many cancers could be successfully treated if the patient consulted the doctor sufficiently early. But how can a developing cancer be detected if it doesn't give rise to any symptoms? In the near future, suitably early diagnosis could be provided by simple and cheap chemical sensors - thanks to special recognizing polymer films developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.
Men's hidden fears about body fat are fuelling gym attendance motivated by feelings of guilt and shame rather than a desire to build muscle, new research has shown.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heidi Lynn Sensenig, OD 50 Berkshire Ct, Wyomissing, PA 19610-1219 Ph: (610) 374-3134 | Dr Heidi Lynn Sensenig, OD 50 Berkshire Ct, Wyomissing, PA 19610-1219 Ph: (610) 374-3134 |
News Archive
Angiotensin, Angiotensin-Converting Enzyme 2, Cell, Coronavirus, Enzyme, Glycoprotein, Neck, Protein, Receptor, Respiratory, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Virus, SARS-CoV-2, Coronavirus Disease COVID-19,
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
Integrated Modular Systems, Inc. (IMSI) has announced OneList™, a unified worklist at RSNA 2010. IMSI will be in Booth 4606 at RSNA 2010 (the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America) November 27, 2010-December 3, 2010 at McCormick Place in Chicago, IL.
Many cancers could be successfully treated if the patient consulted the doctor sufficiently early. But how can a developing cancer be detected if it doesn't give rise to any symptoms? In the near future, suitably early diagnosis could be provided by simple and cheap chemical sensors - thanks to special recognizing polymer films developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.
Men's hidden fears about body fat are fuelling gym attendance motivated by feelings of guilt and shame rather than a desire to build muscle, new research has shown.
› Verified 6 days ago
Elizabeth Abigail Harris, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1901 Ridgewood Road, Wyomissing, PA 19610 Phone: 610-373-2300 Fax: 610-373-7014 | |
Eye Consultants Of Pennsylvania, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1 Granite Point Dr Ste 100, Wyomissing, PA 19610 Phone: 610-378-1344 Fax: 610-378-5169 | |
Dr. Nicole M Forney, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2630 Westview Dr, Wyomissing, PA 19610 Phone: 610-376-1981 Fax: 610-376-3153 | |
Dr. Mark Falon Landau, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 555 Van Reed Rd, Wyomissing, PA 19610 Phone: 610-378-5560 Fax: 610-378-1400 | |
Dr. Mark D Lachman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1665 State Hill Rd, Suite 910, Wyomissing, PA 19610 Phone: 610-374-3777 | |
Dr. Lucinda Ann Kauffman, OD, FAAO Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Granite Point Dr Ste 100, Wyomissing, PA 19610 Phone: 610-378-1344 Fax: 610-378-5169 | |
Linsey Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1901 Ridgewood Ave, Wyomissing, PA 19610 Phone: 610-373-2300 Fax: 610-373-7014 |